These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9581813)

  • 1. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
    Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib sensitizes CLL lymphocytes to chlorambucil.
    Aloyz R; Grzywacz K; Xu ZY; Loignon M; Alaoui-Jamali MA; Panasci L
    Leukemia; 2004 Mar; 18(3):409-14. PubMed ID: 14712290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
    Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
    Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
    Muller C; Christodoulopoulos G; Salles B; Panasci L
    Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
    Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
    J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks.
    Chernikova SB; Wells RL; Elkind MM
    Radiat Res; 1999 Feb; 151(2):159-66. PubMed ID: 9952300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
    Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
    Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
    Svirnovski AI; Serhiyenka TF; Kustanovich AM; Khlebko PV; Fedosenko VV; Taras IB; Bakun AV
    Exp Oncol; 2010 Dec; 32(4):258-62. PubMed ID: 21270755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
    Begleiter A; Wang H; Verburg L; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-dependent protein kinase in leukaemia cells and correlation with drug sensitivity.
    Eriksson A; Lewensoh R; Larsson R; Nilsson A
    Anticancer Res; 2002; 22(3):1787-93. PubMed ID: 12168870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
    Sarkaria JN; Tibbetts RS; Busby EC; Kennedy AP; Hill DE; Abraham RT
    Cancer Res; 1998 Oct; 58(19):4375-82. PubMed ID: 9766667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
    Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin.
    Kim SH; Um JH; Dong-Won B; Kwon BH; Kim DW; Chung BS; Kang CD
    Leuk Res; 2000 Nov; 24(11):917-25. PubMed ID: 11086175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.
    Elliott SL; Crawford C; Mulligan E; Summerfield G; Newton P; Wallis J; Mainou-Fowler T; Evans P; Bedwell C; Durkacz BW; Willmore E
    Br J Haematol; 2011 Jan; 152(1):61-71. PubMed ID: 21083655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.
    Müller MR; Buschfort C; Thomale J; Lensing C; Rajewsky MF; Seeber S
    Clin Cancer Res; 1997 Nov; 3(11):2055-61. PubMed ID: 9815597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inactivation of DNA-dependent protein kinase with antisense oligodeoxynucleotides: consequences for the rejoining of radiation-induced DNA double-strand breaks and radiosensitivity of human cancer cell lines.
    Sak A; Stuschke M; Wurm R; Schroeder G; Sinn B; Wolf G; Budach V
    Cancer Res; 2002 Nov; 62(22):6621-4. PubMed ID: 12438258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DNA-dependent protein kinase activity in leukemic cells.
    Muller C; Salles B
    Oncogene; 1997 Nov; 15(19):2343-8. PubMed ID: 9393878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
    Silber R; Degar B; Costin D; Newcomb EW; Mani M; Rosenberg CR; Morse L; Drygas JC; Canellakis ZN; Potmesil M
    Blood; 1994 Nov; 84(10):3440-6. PubMed ID: 7949099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
    Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.